MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Effect of perception of vertical position on forward flexion posture in patients with Parkinson’s disease: A multicenter, observational study (interim report)

    M. Shiraishi, K. Mikami, H. Kamo, T. Kamo, T. Tsunemi, Y. Okuma, K. Fujimoto, Y. Yokota, S. Nogawa, T. Osada, M. Seki, H. Nagayama, T. Hatano, H. Nakajima, K. Suzuki, T. Yamamoto, Y. Yamano, N. Hattori, M. Ijima (Kawasaki, Japan)

    Objective: This study investigated the effects of subjective vertical position, which a PD patient subjectively perceives as the vertical position, in exacerbating forward flexion posture…
  • 2022 International Congress

    Multi-modal prognostic biomarkers for Parkinson’s disease progression and severity

    AS. Rolland, M. Dutheil, O. Simonin, R. Viard, V. Huin, M. Kyheng, C. Moreau, S. Thobois, A. Eusebio, E. Hainque, I. Benatru, D. Maltete, C. Giordana, M. Tir, C. Hubsch, B. Jarraya, F. Durif, C. Brefel-Courbon, O. Rascol, JC. Corvol, G. Garçon, D. Devos (Lille, France)

    Objective: To determine a pathophysiological panel of biomarkers significantly associated with the severity and the disease progression of Parkinson’s disease. Background: Detecting, monitoring and predicting…
  • 2022 International Congress

    Anthropometric Changes in Parkinson’s Disease: Canadian Longitudinal Study on Aging

    S. Zolfaghari, A. Pelletier, R. Postuma (Montreal, Canada)

    Objective: To explore the predictive role of anthropometric changes and development of Parkinson’s Disease (PD). Background: There is a tendency to lose weight in PD,…
  • 2022 International Congress

    Apomorphine Hydrochloride Injection Treatment Initiations in the Presence and Absence of an Antiemetic in People with Parkinson Disease

    C. Happel, M. Grall, B. Lujan, A. Formella (Rockville, USA)

    Objective: To provide real-world experience regarding apomorphine treatment initiations with or without concomitant antiemetic prophylaxis. Background: Apomorphine hydrochloride (apo) injection, administered subcutaneously, is an “on-demand’…
  • 2022 International Congress

    Worse Sleep Quality Aggravates the Motor and Non-Motor Symptoms in Parkinson’s Disease

    Y. Qu, YP. Chen, L. Li, JY. Li, QX. Qin, DL. Wang, JW. Zhao, ZJ. Mao, YJ. Xiong, Z. Min, Z. Xue (Wuhan, China)

    Objective: The current study aims to investigate the association of sleep characteristics with motor and non-motor dysfunctions of Parkinson’s disease (PD) in a single-center, observational,…
  • 2022 International Congress

    New-onset gait problems after bilateral STN-DBS for Parkinson’s disease: A systematic review

    J. Janssen Daalen, A. Selvaraj, D. Georgiev, B. Bloem, R. Bartels, R. Esselink, S. Vinke (Nijmegen, Netherlands)

    Objective: In this systematic review, we provide an overview of an underrecognized, but common side effect related to deep brain stimulation of the subthalamic nucleus…
  • 2022 International Congress

    SelfCog®: a digitized cognitive battery to classify Parkinson disease (PD) patients with or without Mild Cognitive Impairment (MCI)

    J. Montillot, R. Massart, K. Hernandez, M. Lunven, G. Fénelon, H. Salhi, A. Bachoud-Lévi, P. Rémy (Créteil, France)

    Objective: We tested the performance of the SelfCog® to classify PD patients as MCI. Background: MCI is a strong risk factor of dementia in PD…
  • 2022 International Congress

    Measuring what matters in Parkinson’s disease – validating real-world digital mobility outcomes for widespread adoption

    A. Yarnall, C. Schlenstedt, P. Ginis, H. Hildesheim, A. Mirelman, J. Hausdorff, A. Nieuwboer, H. Gassner, L. Alcock, P. Brown, H. Hunter, I. Neatrour, L. Sutcliffe, J. Winkler, J. Klucken, J. Kudelka, M. Gordon, C. Becker, W. Maetzler, L. Rochester (Newcastle, United Kingdom)

    Objective: To validate and support widespread adoption of real-world digital mobility outcomes (DMOs) to monitor mobility performance, disease progression and predict falls in patients with…
  • 2022 International Congress

    Comparison of different risk scores for Parkinson’s disease in a population-based 10-year study

    K. Marini, K. Seppi, S. Kiechl, H. Stockner, P. Willeit, J. Willeit, A. Djamshidian-Tehrani, G. Rungger, W. Poewe, P. Mahlknecht (Innsbruck, Austria)

    Objective: To validate the “enhanced” PREDICT-PD algorithm in a longitudinal population-based cohort and compare its performance with other Parkinson's disease risk scores in identifying cases…
  • 2022 International Congress

    Geographic and Financial Trends in the Utilization of Deep Brain Stimulation in the Medicare Population from 2013-2019

    T. Gossard, A. Khurana, J. Chan, S. Aslam (Phoenix, USA)

    Objective: To evaluate the utilization of deep brain stimulation within the Medicare population across different regions and states in the United States Background: Deep brain…
  • « Previous Page
  • 1
  • …
  • 125
  • 126
  • 127
  • 128
  • 129
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley